HOME > Research
Visitor：1563
Cardiovascular health
- ● Awarded US patent No. 4,897,265 for cardiovascular protection(20).
- ● Demonstrated in human clinical trials, that the product can contribute to lower systolic and diastolic blood pressure, as well as lower total blood cholesterol levels, LDL cholesterol and atherogenic index(18, 19).
- ● AIFs may contribute to the reduction in the formation of arterial plaque(16).
- ● The effect of the product on reducing the formation of arterial plaque is clearly better than the cholesterol-lowering drug Mevacor®(16).
Immune today, healthy everyday.
These statements have not been evaluated by the Food and Drug Administration.
The products mentioned here are not intended to diagnose, treat, cure or prevent any disease.